Pharma Journalist -

OPKO Health, Inc. announced the acquisition of ModeX Therapeutics, Inc. a privately held biotechnology company focused on developing innovative multi-specific immune therapies for…
Read More...

Aztiq Pharma Partners ("Aztiq"), a private equity company led by Alvogen Founder and Chairman Róbert Wessman, and Innobic (Asia) Company Limited ("Innobic") have completed the…
Read More...

InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug resistance for hard-to-treat solid…
Read More...

Do you want to be part of the largest gathering of mRNA professionals? The 2nd Annual mRNA-Based Therapeutics Summit is returning to Boston this July. Expect exclusive data from the…
Read More...

Citius Pharmaceuticals, Inc. a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, announced that it has selected Biorasi, LLC…
Read More...

Illumina, Inc. a global leader in DNA sequencing and array-based technologies, and Deerfield Management, a healthcare investment management firm, announced a five-year partnership to…
Read More...

ADVANZ PHARMA Corp. Limited, a UK-headquartered pharmaceutical company with a strategic focus on specialty and hospital pharmaceuticals in Europe, has signed an agreement with Intercept…
Read More...

Orion enters into exclusive agreement with Jemincare for novel non-opioid drug candidate for the treatment of pain Orion Corporation has entered into an agreement with Chinese…
Read More...

Myovant Sciences and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for MYFEMBREE…
Read More...

Novartis announced the European Commission (EC) has approved Jakavi (ruxolitinib) for the treatment of patients aged 12 years and older with acute or chronic GvHD who have inadequate…
Read More...